1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Biological Therapy Analysis & Statistics, August 2016 (p6)

Biological Therapy Analysis & Statistics, August 2016 (p6)

24/7 Customer Support

Talk to Veronica

+1 718 514 2762

151-180 of about 900 reports

Purchase Reports From Reputable Market Research Publishers

Growth Hormone Antagonists -Pipeline Insights, 2016

Growth Hormone Antagonists -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • August 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Growth Hormone Antagonists-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Growth Hormone Antagonists. ...

  • Industries : Biological Therapy, Biopharmaceutical
Fibroblast Activation Protein (FAP or Seprase) Inhibitors -Pipeline Insights, 2016

Fibroblast Activation Protein (FAP or Seprase) Inhibitors -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • August 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Fibroblast Activation Protein (FAP or Seprase) Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities ...

  • Industries : Biological Therapy, Biopharmaceutical, Biotechnology
Interleukin (IL) Inhibitors -Pipeline Insights, 2016

Interleukin (IL) Inhibitors -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • August 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Interleukin (IL) Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Interleukin (IL) ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor 1 (FGFR1) Agonists -Pipeline Insights, 2016

Fibroblast Growth Factor Receptor 1 (FGFR1) Agonists -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • August 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Fibroblast Growth Factor Receptor 1 (FGFR1) Agonists-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors -Pipeline Insights, 2016

Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • August 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities ...

  • Industries : Biological Therapy
G-CSF Inhibitors -Pipeline Insights, 2016

G-CSF Inhibitors -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • August 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “G-CSF Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the G-CSF Inhibitors. The DelveInsight’s ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors -Pipeline Insights, 2016

Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • August 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities ...

  • Industries : Biological Therapy
T-cell Immunotherapy: Clinical Trial Tracker

T-cell Immunotherapy: Clinical Trial Tracker

  • $ 949
  • Industry report
  • July 2016
  • by Roots Analysis Private Ltd.

INTRODUCTION After years of research tracing back to the 18th century, a gamut of novel therapies namely, CAR-T, TCR and TIL therapies, have finally reached a point of maturity. These promising therapeutic ...

  • Industries : Biological Therapy
  • Countries : United States
RNAs (miRNA, RNAi & siRNA) in Oncology: Drug Pathway Analyzer

RNAs (miRNA, RNAi & siRNA) in Oncology: Drug Pathway Analyzer

  • $ 900
  • Industry report
  • August 2016
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 102 RNA (miRNA, RNAi & siRNA) drugs known to affect more than 168 specific intracellular signaling pathways ...

  • Industries : Biological Therapy
Competitor Analysis: Bispecific Antibodies for Cancer, Inflammatory & Other Diseases

Competitor Analysis: Bispecific Antibodies for Cancer, Inflammatory & Other Diseases

  • $ 580
  • Industry report
  • June 2016
  • by La Merie Publishing

Competitor Analysis: Bispecific Antibodies for Cancer, Inflammatory & Other DiseasesThis Competitive Intelligence report about Bispecific Antibodies for Cancer, Inflammatory & Other Diseases evaluates ...

  • Industries : Biological Therapy, Biotechnology, Biopharmaceutical
Invitro meat:Patent Overview

Invitro meat:Patent Overview

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

In vitro meat, cultured meat, or test tube meat is flesh for consumption that is grown in an artificial environment rather than harvested from a slaughtered animal. Originally, the research on in vitro ...

  • Industries : Biological Therapy
Stem Cell –Patent Overview in the years 2011 - 2016

Stem Cell –Patent Overview in the years 2011 - 2016

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

A stem cell is an undifferentiated cell that has the potential to develop into any type of cell in the body. It is one of the most promising markets in the field of life sciences at present and forecasted ...

  • Industries : Biological Therapy
Regenerative Medicines Market outlook -  Market size, segmentation, market share and competitive landscape (2016-2021)

Regenerative Medicines Market outlook - Market size, segmentation, market share and competitive landscape (2016-2021)

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

The Global Regenerative Medicines Market was valued at USD 16.4 billion in 2014 and is forecasted to reach USD 67.6 billion by 2020, growing at a CAGR of 18.9% during the forecast period from 2014 to 2019. ...

  • Industries : Biological Therapy, Biotechnology
  • Countries : World
Treatment of Sézary Syndrome - Patent Overview in the years 2011 - 2016

Treatment of Sézary Syndrome - Patent Overview in the years 2011 - 2016

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

Sézary syndrome is an erythrodermic form of cutaneous T-Cell lymphoma (CTCL), a term that collectively includes all cutaneous lymphomas arising from T lymphocytes. The syndrome is named after Albert Sézary, ...

  • Industries : Biological Therapy
Vitamin E as A Feed Vitamin in Poultry:Patent Overview

Vitamin E as A Feed Vitamin in Poultry:Patent Overview

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

Vitamin E at high supplementation levels has a strong immune response with enhancing resistance of poultry to infectious diseases. Vitamin E affects both cellular and humoral immune function; T lymphocytes ...

  • Industries : Biological Therapy, OTC
RNAi Technology  -  Market size, segmentation, market share and competitive landscape (2016-2021)

RNAi Technology - Market size, segmentation, market share and competitive landscape (2016-2021)

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

The Global RNAi Technology Market is estimated US$ 8.7 billion in 2014 and is estimated to reach US$ 21.9 billion by 2019 with a CAGR of 20.19%. RNA interference (RNAi) is a natural process of treating ...

  • Industries : Biological Therapy
  • Countries : World
Stem Cell Market outlook -  Market size, segmentation, market share and competitive landscape (2016-2021)

Stem Cell Market outlook - Market size, segmentation, market share and competitive landscape (2016-2021)

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

The global stem cells market has been estimated at 12 USD billion in 2014 and is projected to reach USD 26.6 billion by 2020 at a CAGR of 13.7% during the forecast period 2014 to 2020. Stem cell is an ...

  • Industries : Biological Therapy
  • Countries : World
Vitamin E as A Feed Vitamin in Livestock:Patent Overview

Vitamin E as A Feed Vitamin in Livestock:Patent Overview

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

Vitamin E at high supplementation levels has a strong immune response with enhancing resistance of poultry to infectious diseases. Vitamin E affects both cellular and humoral immune function; T lympocytes ...

  • Industries : Biological Therapy, OTC
Vitamin E as A Feed Vitamin in Crustaceans : Patent Overview

Vitamin E as A Feed Vitamin in Crustaceans : Patent Overview

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

Vitamin E at high supplementation levels has a strong immune response with enhancing resistance of poultry to infectious diseases. In one of the studies it was revealed that Vitamin E affects both cellula ...

  • Industries : Biological Therapy, OTC
Treatment of Cutaneous T-Cell Lymphoma - Patent Overview in the years 2011 - 2016

Treatment of Cutaneous T-Cell Lymphoma - Patent Overview in the years 2011 - 2016

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

Cutaneous lymphomas are a distinct subset of non-Hodgkin’s lymphoma. They are cancers of lymphocytes (white blood cells) that primarily involve the skin. Classification is based on lymphocyte type - ...

  • Industries : Biological Therapy
Treatment of Chronic Lymphocytic Leukemia (CLL) - Patent Overview in the years 2011 - 2016

Treatment of Chronic Lymphocytic Leukemia (CLL) - Patent Overview in the years 2011 - 2016

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

CLL is a condition where you have many abnormal B lymphocytes. The lymphocytes look normal under a microscope, but are abnormal as they do not function properly. The main reason for the build-up of the ...

  • Industries : Biological Therapy
RNAi Technology - Patent Overview in the years 2011 - 2016

RNAi Technology - Patent Overview in the years 2011 - 2016

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

RNA interference (RNAi) is a natural process of treating forms of cancer and other diseases by post-transcriptional silencing of genes by small fragments of the nucleic acid. But the path of RNAi therapies ...

  • Industries : Biological Therapy
miRagen Therapeutics, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

miRagen Therapeutics, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2016
  • by MarketLine

Summary Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an ...

  • Industries : Therapy
  • Countries : United States
Cellular Dynamics International, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Cellular Dynamics International, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2016
  • by MarketLine

Summary Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an ...

  • Countries : United States
BioHeart, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

BioHeart, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2016
  • by MarketLine

Summary Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an ...

  • Industries : Biological Therapy
  • Countries : United States
Tekmira Pharmaceuticals Corporation – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Tekmira Pharmaceuticals Corporation – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2016
  • by MarketLine

Summary Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an ...

  • Industries : Pharmaceutical
  • Countries : United States
LFB S.A – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

LFB S.A – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2016
  • by MarketLine

Summary Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an ...

  • Industries : Biotechnology
  • Countries : United Kingdom, France
Northwest Biotherapeutics, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Northwest Biotherapeutics, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2016
  • by MarketLine

Summary Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an ...

  • Industries : Biological Therapy, Biotechnology
  • Countries : United States
Opus Bio, Inc. (formerly Lentigen Corporation) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Opus Bio, Inc. (formerly Lentigen Corporation) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2016
  • by MarketLine

Summary Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an ...

  • Countries : United States
Vivalis SA – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Vivalis SA – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2016
  • by MarketLine

Summary Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an ...

  • Industries : Biopharmaceutical, Pharmaceutical, Therapy
  • Countries : France

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.